| An inhibitor of the mammalian target of sirolimus (mTOR) is used as an agent for immunosuppression of solid organ transplantation. Its advantages include lack of nephrotoxicity and a lower incidence of post-transplant cancers and thrombotic microangiopathy. Delayed wound healing, proteinuria and pulmonary infiltration are reported complications of sirolimus. |
| نویسنده | نفر چندم مقاله |
|---|---|
| محمد رضا اردلان | اول |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| 107.pdf | 1398/02/07 | 315574 | دانلود |